PDCD1 and neoplasm: CLL monocytes show enhanced PD-1 expression compared to healthy donors, and ligation with recombinant PD-L1 diminishes monocytes switch to aerobic glycolysis, while anti-PD-L1 blockade reverts this effect, promoting phagocytosis of tumor cells (215).